These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 2758765

  • 1. Role of thromboxane A2 as a mediator of platelet-activating-factor-induced aggregation of human platelets.
    McCulloch RK, Summers J, Vandongen R, Rouse IL.
    Clin Sci (Lond); 1989 Jul; 77(1):99-103. PubMed ID: 2758765
    [Abstract] [Full Text] [Related]

  • 2. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F, Vargaftig BB.
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [Abstract] [Full Text] [Related]

  • 3. Platelet aggregation in the Asian elephant is not dependent on thromboxane B2 production.
    Gentry PA, Niemuller C, Ross ML, Liptrap RM.
    Comp Biochem Physiol A Comp Physiol; 1989 Nov; 94(1):47-51. PubMed ID: 2571453
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration.
    Violi F, Pratico D, Ghiselli A, Alessandri C, Iuliano L, Cordova C, Balsano F.
    Atherosclerosis; 1990 Jun; 82(3):247-52. PubMed ID: 2115784
    [Abstract] [Full Text] [Related]

  • 5. The role of thromboxane A2 in increased whole blood platelet aggregation in oral contraceptive users.
    Norris LA, Devitt M, Bonnar J.
    Thromb Res; 1996 Feb 15; 81(4):407-17. PubMed ID: 8907290
    [Abstract] [Full Text] [Related]

  • 6. The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid.
    Taylor ML, Misso NL, Stewart GA, Thompson PJ.
    Br J Clin Pharmacol; 1992 Jan 15; 33(1):25-31. PubMed ID: 1540486
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
    Cattaneo M, Canciani MT, Mannucci PM.
    Thromb Haemost; 1985 Apr 22; 53(2):221-4. PubMed ID: 3927505
    [Abstract] [Full Text] [Related]

  • 9. Differential effect of aspirin on platelet aggregation in IDDM.
    Mori TA, Vandongen R, Douglas AJ, McCulloch RK, Burke V.
    Diabetes; 1992 Mar 22; 41(3):261-6. PubMed ID: 1551486
    [Abstract] [Full Text] [Related]

  • 10. Platelet activating factor (PAF) causes human platelet aggregation through the mechanism of membrane modulation.
    Rao GH, White JG.
    Prostaglandins Leukot Med; 1982 Oct 22; 9(4):459-72. PubMed ID: 6817343
    [Abstract] [Full Text] [Related]

  • 11. [The effects of platelet-activating factor (PAF) on the collagen-induced whole blood aggregation].
    Oura Y.
    Rinsho Byori; 1994 Jan 22; 42(1):63-9. PubMed ID: 8107285
    [Abstract] [Full Text] [Related]

  • 12. Amplification of primary response of human platelets to platelet-activating factor: aspirin-sensitive and aspirin-insensitive pathways.
    Lauri D, Cerletti C, de Gaetano G.
    J Lab Clin Med; 1985 Jun 22; 105(6):653-8. PubMed ID: 3923145
    [Abstract] [Full Text] [Related]

  • 13. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS, Wharton KA, White BP, Lumley P.
    Br J Pharmacol; 1991 Feb 22; 102(2):497-505. PubMed ID: 1826620
    [Abstract] [Full Text] [Related]

  • 14. Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man.
    Küster LJ, Frölich JC.
    Prostaglandins; 1986 Sep 22; 32(3):415-23. PubMed ID: 3097760
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL, Rand ML, Barrow DV, Packham MA.
    Atherosclerosis; 1991 May 22; 88(1):77-86. PubMed ID: 1878012
    [Abstract] [Full Text] [Related]

  • 18. Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation.
    Nunn B.
    Thromb Res; 1983 Sep 01; 31(5):657-63. PubMed ID: 6648898
    [Abstract] [Full Text] [Related]

  • 19. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.
    Ostermann G, Hofmann B, Kertscher HP, Till U.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec 01; 342(6):713-8. PubMed ID: 2096302
    [Abstract] [Full Text] [Related]

  • 20. Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generation.
    Macconi D, Viganò G, Bisogno G, Galbusera M, Orisio S, Remuzzi G, Livio M.
    Am J Kidney Dis; 1992 Apr 01; 19(4):318-25. PubMed ID: 1562019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.